Evaluating M2BPGi as a Marker for Liver Fibrosis in Patients with Chronic Hepatitis B.

Hoang Huu BuiSuong Thi-Bang NguyenSang The PhanKhue Minh NguyenChuong Dinh Nguyen

Published in: Digestive diseases and sciences (2023)

With cut-off values of 0.79 C.O.I and 1.3 C.O.I, M2BPGi could be an effective method for diagnosing significant fibrosis and cirrhosis in CHB patients, respectively.

Keyphrases

liver fibrosis
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
prognostic factors